Hwang TJ - Search Results

1

Value-Based Pricing and State Reform of Prescription Drug Costs.

Hwang TJ, Kesselheim AS, Sarpatwari A. Hwang TJ, et al. JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255. JAMA. 2017. PMID: 28692713 No abstract available.

2

Life cycle of medical product rules issued by the US Food and Drug Administration.

Hwang TJ, Avorn J, Kesselheim AS. Hwang TJ, et al. J Health Polit Policy Law. 2014 Aug;39(4):751-80. doi: 10.1215/03616878-2743027. Epub 2014 May 19. J Health Polit Policy Law. 2014. PMID: 24842974

3

Target small firms for antibiotic innovation.

Hwang TJ, Carpenter D, Kesselheim AS. Hwang TJ, et al. Science. 2014 May 30;344(6187):967-9. doi: 10.1126/science.1251419. Science. 2014. PMID: 24876477 No abstract available.

4

Drug safety in the digital age.

Hwang TJ, Bourgeois FT, Seeger JD. Hwang TJ, et al. N Engl J Med. 2014 Jun 26;370(26):2460-2. doi: 10.1056/NEJMp1401767. N Engl J Med. 2014. PMID: 24963564 No abstract available.

5

New regulatory paradigms for innovative drugs to treat pediatric diseases.

Hwang TJ, Bourgeois FT. Hwang TJ, et al. JAMA Pediatr. 2014 Oct;168(10):879-80. doi: 10.1001/jamapediatrics.2014.904. JAMA Pediatr. 2014. PMID: 25111315 Free PMC article. No abstract available.

6

Retinal implants and Medicare reimbursement policies for breakthrough treatments in ophthalmology.

Hwang TJ, Ciolino JB. Hwang TJ, et al. JAMA Ophthalmol. 2015 Apr;133(4):373-4. doi: 10.1001/jamaophthalmol.2015.54. JAMA Ophthalmol. 2015. PMID: 25675029 Free PMC article. No abstract available.

7

Paying for innovation: reimbursement incentives for antibiotics.

Hwang TJ, Carpenter D, Kesselheim AS. Hwang TJ, et al. Sci Transl Med. 2015 Feb 25;7(276):276fs9. doi: 10.1126/scitranslmed.aaa1429. Sci Transl Med. 2015. PMID: 25717095 No abstract available.

8

Precision medicine and the FDA's draft guidance on laboratory-developed tests.

Hwang TJ, Lehmann LS, Kesselheim AS. Hwang TJ, et al. Nat Biotechnol. 2015 May;33(5):449-51. doi: 10.1038/nbt.3221. Nat Biotechnol. 2015. PMID: 25965745 No abstract available.

9

Accelerating innovation in rapid diagnostics and targeted antibacterials.

Hwang TJ, Powers JH, Carpenter D, Kesselheim AS. Hwang TJ, et al. Nat Biotechnol. 2015 Jun;33(6):589-90. doi: 10.1038/nbt.3251. Nat Biotechnol. 2015. PMID: 26057972 No abstract available.

10

Two decades of new drug development for central nervous system disorders.

Kesselheim AS, Hwang TJ, Franklin JM. Kesselheim AS, et al. Among authors: hwang tj. Nat Rev Drug Discov. 2015 Dec;14(12):815-6. doi: 10.1038/nrd4793. Epub 2015 Nov 20. Nat Rev Drug Discov. 2015. PMID: 26585536 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results